Mechanism and therapeutic window of a genistein nanosuspension to protect against hematopoietic-acute radiation syndrome

There are no FDA-approved drugs that can be administered prior to ionizing radiation exposure to prevent hematopoietic–acute radiation syndrome (H-ARS). A suspension of synthetic genistein nanoparticles was previously shown to be an effective radioprotectant against H-ARS when administered prior to...

Full description

Saved in:
Bibliographic Details
Published in:J Radiat Res
Main Authors: Landauer, Michael R, Harvey, Adam J, Kaytor, Michael D, Day, Regina M
Format: Artigo
Language:Inglês
Published: Oxford University Press 2019
Subjects:
Regular Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6530628/
https://ncbi.nlm.nih.gov/pubmed/31038675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jrr/rrz014
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items